Skip to main content
. 2019 Feb 8;20(3):726. doi: 10.3390/ijms20030726

Figure 1.

Figure 1

Contribution of renin–angiotensin system-mediated actions in the epileptogenesis process. Exacerbation of epilepsy pathophysiology through predominance of the Ang II/ATR1 axis, and available targeted therapeutic strategy through RAS enzyme inhibitors; ATR1 antagonists; and ATR2, MasR, MrgD, and ATR4 agonists that mediate beneficial actions in epilepsy pathophysiology and related consequences.